PODCAST · health
The ARTNet Podcast
by NCI ARTNet
Why do cancer treatments work for some patients at first, only to stop working later? In the premiere episode of the ARTNet Podcast, we speak with Dr. Jeffrey Tyner from Oregon Health & Science University about the complex biology behind acquired resistance to cancer therapies.Dr. Tyner shares insights into how cancer cells adapt and survive treatment, the critical role of the tumor microenvironment, and why understanding resistance mechanisms is essential for developing more durable therapies. The conversation also explores how collaboration across the ARTNet Consortium is helping researchers connect data, models, and expertise to better understand cancer relapse and treatment failure.From leukemia research to large-scale data sharing, this episode offers an inside look at one of the biggest challenges in modern oncology — and the scientific efforts underw
No episodes available yet.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Why do cancer treatments work for some patients at first, only to stop working later? In the premiere episode of the ARTNet Podcast, we speak with Dr. Jeffrey Tyner from Oregon Health & Science University about the complex biology behind acquired resistance to cancer therapies.Dr. Tyner shares insights into how cancer cells adapt and survive treatment, the critical role of the tumor microenvironment, and why understanding resistance mechanisms is essential for developing more durable therapies. The conversation also explores how collaboration across the ARTNet Consortium is helping researchers connect data, models, and expertise to better understand cancer relapse and treatment failure.From leukemia research to large-scale data sharing, this episode offers an inside look at one of the biggest challenges in modern oncology — and the scientific efforts underw
HOSTED BY
NCI ARTNet
Loading similar podcasts...